Skip to main content
Home
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!

Languages

Search form

Main menu

  • Home
  • Search
  • Category Search
  • Log In
  • Peoples Court
  • Recent posts
  • Treatment Protocols

You are here

Home

Procarbazine

Title Average Ratingsort ascending
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. 90.00%
Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma 70.00%
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r 70.00%